Global Multiple Myeloma Therapy Market Research Report 2023
Multiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which collect near the bone marrow and hamper normal functioning of the healthy plasma cells.
According to QYResearch’s new survey, global Multiple Myeloma Therapy market is projected to reach US$ 33160 million in 2029, increasing from US$ 21620 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multiple Myeloma Therapy market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Myeloma Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Multiple Myeloma Therapy market is projected to reach US$ 33160 million in 2029, increasing from US$ 21620 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multiple Myeloma Therapy market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Myeloma Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Sanofi
- Celgene
- Johnson & Johnson
- GlaxoSmithKline plc
- Roche
- AbbVie Inc.
- Amgen Inc.
- Novartis AG
- Millennium Pharmaceuticals
- Innate Pharma SA
- Targeted Therapy
- Chemotherapy
- Radiotherapy
- Bone Marrow Transplant
- Others
- Hospital
- Clinic
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Bone Marrow Transplant
1.2.6 Others
1.3 Market by Application
1.3.1 Global Multiple Myeloma Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Multiple Myeloma Therapy Market Perspective (2018-2029)
2.2 Multiple Myeloma Therapy Growth Trends by Region
2.2.1 Global Multiple Myeloma Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multiple Myeloma Therapy Historic Market Size by Region (2018-2023)
2.2.3 Multiple Myeloma Therapy Forecasted Market Size by Region (2024-2029)
2.3 Multiple Myeloma Therapy Market Dynamics
2.3.1 Multiple Myeloma Therapy Industry Trends
2.3.2 Multiple Myeloma Therapy Market Drivers
2.3.3 Multiple Myeloma Therapy Market Challenges
2.3.4 Multiple Myeloma Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Multiple Myeloma Therapy Players by Revenue
3.1.1 Global Top Multiple Myeloma Therapy Players by Revenue (2018-2023)
3.1.2 Global Multiple Myeloma Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Multiple Myeloma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiple Myeloma Therapy Revenue
3.4 Global Multiple Myeloma Therapy Market Concentration Ratio
3.4.1 Global Multiple Myeloma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapy Revenue in 2022
3.5 Multiple Myeloma Therapy Key Players Head office and Area Served
3.6 Key Players Multiple Myeloma Therapy Product Solution and Service
3.7 Date of Enter into Multiple Myeloma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MULTIPLE MYELOMA THERAPY BREAKDOWN DATA BY TYPE
4.1 Global Multiple Myeloma Therapy Historic Market Size by Type (2018-2023)
4.2 Global Multiple Myeloma Therapy Forecasted Market Size by Type (2024-2029)
5 MULTIPLE MYELOMA THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global Multiple Myeloma Therapy Historic Market Size by Application (2018-2023)
5.2 Global Multiple Myeloma Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Multiple Myeloma Therapy Market Size (2018-2029)
6.2 North America Multiple Myeloma Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multiple Myeloma Therapy Market Size by Country (2018-2023)
6.4 North America Multiple Myeloma Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Multiple Myeloma Therapy Market Size (2018-2029)
7.2 Europe Multiple Myeloma Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multiple Myeloma Therapy Market Size by Country (2018-2023)
7.4 Europe Multiple Myeloma Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Multiple Myeloma Therapy Market Size (2018-2029)
8.2 Asia-Pacific Multiple Myeloma Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Multiple Myeloma Therapy Market Size (2018-2029)
9.2 Latin America Multiple Myeloma Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multiple Myeloma Therapy Market Size by Country (2018-2023)
9.4 Latin America Multiple Myeloma Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Multiple Myeloma Therapy Market Size (2018-2029)
10.2 Middle East & Africa Multiple Myeloma Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Multiple Myeloma Therapy Introduction
11.1.4 Sanofi Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene Multiple Myeloma Therapy Introduction
11.2.4 Celgene Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.2.5 Celgene Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Multiple Myeloma Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Detail
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Multiple Myeloma Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Multiple Myeloma Therapy Introduction
11.5.4 Roche Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.5.5 Roche Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Detail
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Multiple Myeloma Therapy Introduction
11.6.4 AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.6.5 AbbVie Inc. Recent Development
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Detail
11.7.2 Amgen Inc. Business Overview
11.7.3 Amgen Inc. Multiple Myeloma Therapy Introduction
11.7.4 Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.7.5 Amgen Inc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Multiple Myeloma Therapy Introduction
11.8.4 Novartis AG Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.8.5 Novartis AG Recent Development
11.9 Millennium Pharmaceuticals
11.9.1 Millennium Pharmaceuticals Company Detail
11.9.2 Millennium Pharmaceuticals Business Overview
11.9.3 Millennium Pharmaceuticals Multiple Myeloma Therapy Introduction
11.9.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.9.5 Millennium Pharmaceuticals Recent Development
11.10 Innate Pharma SA
11.10.1 Innate Pharma SA Company Detail
11.10.2 Innate Pharma SA Business Overview
11.10.3 Innate Pharma SA Multiple Myeloma Therapy Introduction
11.10.4 Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.10.5 Innate Pharma SA Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Bone Marrow Transplant
1.2.6 Others
1.3 Market by Application
1.3.1 Global Multiple Myeloma Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Multiple Myeloma Therapy Market Perspective (2018-2029)
2.2 Multiple Myeloma Therapy Growth Trends by Region
2.2.1 Global Multiple Myeloma Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multiple Myeloma Therapy Historic Market Size by Region (2018-2023)
2.2.3 Multiple Myeloma Therapy Forecasted Market Size by Region (2024-2029)
2.3 Multiple Myeloma Therapy Market Dynamics
2.3.1 Multiple Myeloma Therapy Industry Trends
2.3.2 Multiple Myeloma Therapy Market Drivers
2.3.3 Multiple Myeloma Therapy Market Challenges
2.3.4 Multiple Myeloma Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Multiple Myeloma Therapy Players by Revenue
3.1.1 Global Top Multiple Myeloma Therapy Players by Revenue (2018-2023)
3.1.2 Global Multiple Myeloma Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Multiple Myeloma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiple Myeloma Therapy Revenue
3.4 Global Multiple Myeloma Therapy Market Concentration Ratio
3.4.1 Global Multiple Myeloma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapy Revenue in 2022
3.5 Multiple Myeloma Therapy Key Players Head office and Area Served
3.6 Key Players Multiple Myeloma Therapy Product Solution and Service
3.7 Date of Enter into Multiple Myeloma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MULTIPLE MYELOMA THERAPY BREAKDOWN DATA BY TYPE
4.1 Global Multiple Myeloma Therapy Historic Market Size by Type (2018-2023)
4.2 Global Multiple Myeloma Therapy Forecasted Market Size by Type (2024-2029)
5 MULTIPLE MYELOMA THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global Multiple Myeloma Therapy Historic Market Size by Application (2018-2023)
5.2 Global Multiple Myeloma Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Multiple Myeloma Therapy Market Size (2018-2029)
6.2 North America Multiple Myeloma Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multiple Myeloma Therapy Market Size by Country (2018-2023)
6.4 North America Multiple Myeloma Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Multiple Myeloma Therapy Market Size (2018-2029)
7.2 Europe Multiple Myeloma Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multiple Myeloma Therapy Market Size by Country (2018-2023)
7.4 Europe Multiple Myeloma Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Multiple Myeloma Therapy Market Size (2018-2029)
8.2 Asia-Pacific Multiple Myeloma Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Multiple Myeloma Therapy Market Size (2018-2029)
9.2 Latin America Multiple Myeloma Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multiple Myeloma Therapy Market Size by Country (2018-2023)
9.4 Latin America Multiple Myeloma Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Multiple Myeloma Therapy Market Size (2018-2029)
10.2 Middle East & Africa Multiple Myeloma Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Multiple Myeloma Therapy Introduction
11.1.4 Sanofi Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene Multiple Myeloma Therapy Introduction
11.2.4 Celgene Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.2.5 Celgene Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Multiple Myeloma Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Detail
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Multiple Myeloma Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Multiple Myeloma Therapy Introduction
11.5.4 Roche Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.5.5 Roche Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Detail
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Multiple Myeloma Therapy Introduction
11.6.4 AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.6.5 AbbVie Inc. Recent Development
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Detail
11.7.2 Amgen Inc. Business Overview
11.7.3 Amgen Inc. Multiple Myeloma Therapy Introduction
11.7.4 Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.7.5 Amgen Inc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Multiple Myeloma Therapy Introduction
11.8.4 Novartis AG Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.8.5 Novartis AG Recent Development
11.9 Millennium Pharmaceuticals
11.9.1 Millennium Pharmaceuticals Company Detail
11.9.2 Millennium Pharmaceuticals Business Overview
11.9.3 Millennium Pharmaceuticals Multiple Myeloma Therapy Introduction
11.9.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.9.5 Millennium Pharmaceuticals Recent Development
11.10 Innate Pharma SA
11.10.1 Innate Pharma SA Company Detail
11.10.2 Innate Pharma SA Business Overview
11.10.3 Innate Pharma SA Multiple Myeloma Therapy Introduction
11.10.4 Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2018-2023)
11.10.5 Innate Pharma SA Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Multiple Myeloma Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiotherapy
Table 5. Key Players of Bone Marrow Transplant
Table 6. Key Players of Others
Table 7. Global Multiple Myeloma Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Multiple Myeloma Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Multiple Myeloma Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Multiple Myeloma Therapy Market Share by Region (2018-2023)
Table 11. Global Multiple Myeloma Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Multiple Myeloma Therapy Market Share by Region (2024-2029)
Table 13. Multiple Myeloma Therapy Market Trends
Table 14. Multiple Myeloma Therapy Market Drivers
Table 15. Multiple Myeloma Therapy Market Challenges
Table 16. Multiple Myeloma Therapy Market Restraints
Table 17. Global Multiple Myeloma Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Multiple Myeloma Therapy Market Share by Players (2018-2023)
Table 19. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2022)
Table 20. Ranking of Global Top Multiple Myeloma Therapy Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiple Myeloma Therapy Product Solution and Service
Table 24. Date of Enter into Multiple Myeloma Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Myeloma Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Multiple Myeloma Therapy Revenue Market Share by Type (2018-2023)
Table 28. Global Multiple Myeloma Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Multiple Myeloma Therapy Revenue Market Share by Type (2024-2029)
Table 30. Global Multiple Myeloma Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Multiple Myeloma Therapy Revenue Market Share by Application (2018-2023)
Table 32. Global Multiple Myeloma Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Multiple Myeloma Therapy Revenue Market Share by Application (2024-2029)
Table 34. North America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Multiple Myeloma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Multiple Myeloma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Multiple Myeloma Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Multiple Myeloma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 49. Sanofi Company Detail
Table 50. Sanofi Business Overview
Table 51. Sanofi Multiple Myeloma Therapy Product
Table 52. Sanofi Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 53. Sanofi Recent Development
Table 54. Celgene Company Detail
Table 55. Celgene Business Overview
Table 56. Celgene Multiple Myeloma Therapy Product
Table 57. Celgene Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 58. Celgene Recent Development
Table 59. Johnson & Johnson Company Detail
Table 60. Johnson & Johnson Business Overview
Table 61. Johnson & Johnson Multiple Myeloma Therapy Product
Table 62. Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 63. Johnson & Johnson Recent Development
Table 64. GlaxoSmithKline plc Company Detail
Table 65. GlaxoSmithKline plc Business Overview
Table 66. GlaxoSmithKline plc Multiple Myeloma Therapy Product
Table 67. GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 68. GlaxoSmithKline plc Recent Development
Table 69. Roche Company Detail
Table 70. Roche Business Overview
Table 71. Roche Multiple Myeloma Therapy Product
Table 72. Roche Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 73. Roche Recent Development
Table 74. AbbVie Inc. Company Detail
Table 75. AbbVie Inc. Business Overview
Table 76. AbbVie Inc. Multiple Myeloma Therapy Product
Table 77. AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 78. AbbVie Inc. Recent Development
Table 79. Amgen Inc. Company Detail
Table 80. Amgen Inc. Business Overview
Table 81. Amgen Inc. Multiple Myeloma Therapy Product
Table 82. Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 83. Amgen Inc. Recent Development
Table 84. Novartis AG Company Detail
Table 85. Novartis AG Business Overview
Table 86. Novartis AG Multiple Myeloma Therapy Product
Table 87. Novartis AG Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 88. Novartis AG Recent Development
Table 89. Millennium Pharmaceuticals Company Detail
Table 90. Millennium Pharmaceuticals Business Overview
Table 91. Millennium Pharmaceuticals Multiple Myeloma Therapy Product
Table 92. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 93. Millennium Pharmaceuticals Recent Development
Table 94. Innate Pharma SA Company Detail
Table 95. Innate Pharma SA Business Overview
Table 96. Innate Pharma SA Multiple Myeloma Therapy Product
Table 97. Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 98. Innate Pharma SA Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 1. Global Multiple Myeloma Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiotherapy
Table 5. Key Players of Bone Marrow Transplant
Table 6. Key Players of Others
Table 7. Global Multiple Myeloma Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Multiple Myeloma Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Multiple Myeloma Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Multiple Myeloma Therapy Market Share by Region (2018-2023)
Table 11. Global Multiple Myeloma Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Multiple Myeloma Therapy Market Share by Region (2024-2029)
Table 13. Multiple Myeloma Therapy Market Trends
Table 14. Multiple Myeloma Therapy Market Drivers
Table 15. Multiple Myeloma Therapy Market Challenges
Table 16. Multiple Myeloma Therapy Market Restraints
Table 17. Global Multiple Myeloma Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Multiple Myeloma Therapy Market Share by Players (2018-2023)
Table 19. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2022)
Table 20. Ranking of Global Top Multiple Myeloma Therapy Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiple Myeloma Therapy Product Solution and Service
Table 24. Date of Enter into Multiple Myeloma Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Myeloma Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Multiple Myeloma Therapy Revenue Market Share by Type (2018-2023)
Table 28. Global Multiple Myeloma Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Multiple Myeloma Therapy Revenue Market Share by Type (2024-2029)
Table 30. Global Multiple Myeloma Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Multiple Myeloma Therapy Revenue Market Share by Application (2018-2023)
Table 32. Global Multiple Myeloma Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Multiple Myeloma Therapy Revenue Market Share by Application (2024-2029)
Table 34. North America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Multiple Myeloma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Multiple Myeloma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Multiple Myeloma Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Multiple Myeloma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 49. Sanofi Company Detail
Table 50. Sanofi Business Overview
Table 51. Sanofi Multiple Myeloma Therapy Product
Table 52. Sanofi Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 53. Sanofi Recent Development
Table 54. Celgene Company Detail
Table 55. Celgene Business Overview
Table 56. Celgene Multiple Myeloma Therapy Product
Table 57. Celgene Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 58. Celgene Recent Development
Table 59. Johnson & Johnson Company Detail
Table 60. Johnson & Johnson Business Overview
Table 61. Johnson & Johnson Multiple Myeloma Therapy Product
Table 62. Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 63. Johnson & Johnson Recent Development
Table 64. GlaxoSmithKline plc Company Detail
Table 65. GlaxoSmithKline plc Business Overview
Table 66. GlaxoSmithKline plc Multiple Myeloma Therapy Product
Table 67. GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 68. GlaxoSmithKline plc Recent Development
Table 69. Roche Company Detail
Table 70. Roche Business Overview
Table 71. Roche Multiple Myeloma Therapy Product
Table 72. Roche Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 73. Roche Recent Development
Table 74. AbbVie Inc. Company Detail
Table 75. AbbVie Inc. Business Overview
Table 76. AbbVie Inc. Multiple Myeloma Therapy Product
Table 77. AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 78. AbbVie Inc. Recent Development
Table 79. Amgen Inc. Company Detail
Table 80. Amgen Inc. Business Overview
Table 81. Amgen Inc. Multiple Myeloma Therapy Product
Table 82. Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 83. Amgen Inc. Recent Development
Table 84. Novartis AG Company Detail
Table 85. Novartis AG Business Overview
Table 86. Novartis AG Multiple Myeloma Therapy Product
Table 87. Novartis AG Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 88. Novartis AG Recent Development
Table 89. Millennium Pharmaceuticals Company Detail
Table 90. Millennium Pharmaceuticals Business Overview
Table 91. Millennium Pharmaceuticals Multiple Myeloma Therapy Product
Table 92. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 93. Millennium Pharmaceuticals Recent Development
Table 94. Innate Pharma SA Company Detail
Table 95. Innate Pharma SA Business Overview
Table 96. Innate Pharma SA Multiple Myeloma Therapy Product
Table 97. Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2018-2023) & (US$ Million)
Table 98. Innate Pharma SA Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Multiple Myeloma Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Multiple Myeloma Therapy Market Share by Type: 2022 VS 2029
Figure 3. Targeted Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Radiotherapy Features
Figure 6. Bone Marrow Transplant Features
Figure 7. Others Features
Figure 8. Global Multiple Myeloma Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Multiple Myeloma Therapy Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Multiple Myeloma Therapy Report Years Considered
Figure 13. Global Multiple Myeloma Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Multiple Myeloma Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Multiple Myeloma Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global Multiple Myeloma Therapy Market Share by Players in 2022
Figure 17. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapy Revenue in 2022
Figure 19. North America Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 21. United States Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 25. Germany Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Multiple Myeloma Therapy Market Share by Region (2018-2029)
Figure 33. China Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 41. Mexico Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 45. Turkey Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Sanofi Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 48. Celgene Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 49. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 50. GlaxoSmithKline plc Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 51. Roche Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 52. AbbVie Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 53. Amgen Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 54. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 55. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 56. Innate Pharma SA Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Figure 1. Global Multiple Myeloma Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Multiple Myeloma Therapy Market Share by Type: 2022 VS 2029
Figure 3. Targeted Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Radiotherapy Features
Figure 6. Bone Marrow Transplant Features
Figure 7. Others Features
Figure 8. Global Multiple Myeloma Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Multiple Myeloma Therapy Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Multiple Myeloma Therapy Report Years Considered
Figure 13. Global Multiple Myeloma Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Multiple Myeloma Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Multiple Myeloma Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global Multiple Myeloma Therapy Market Share by Players in 2022
Figure 17. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapy Revenue in 2022
Figure 19. North America Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 21. United States Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 25. Germany Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Multiple Myeloma Therapy Market Share by Region (2018-2029)
Figure 33. China Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 41. Mexico Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 45. Turkey Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Sanofi Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 48. Celgene Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 49. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 50. GlaxoSmithKline plc Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 51. Roche Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 52. AbbVie Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 53. Amgen Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 54. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 55. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 56. Innate Pharma SA Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
